Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer

Noninvasive circulating tumor DNA (ctDNA) can be used to predict breast cancer recurrence and prognosis. In this study, we detected 226 and 114 somatic variants in tumor DNA from 70 primary breast cancer (PBC) patients (98.59%) and ctDNA from 48 patients (67.61%), respectively. Gene frequencies of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yidong, Xu, Yaping, Gong, Yuhua, Zhang, Yanyan, Lu, Yaping, Wang, Changjun, Yao, Ru, Li, Peng, Guan, Yanfang, Wang, Jiayin, Xia, Xuefeng, Yang, Ling, Yi, Xin, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487710/
https://www.ncbi.nlm.nih.gov/pubmed/30672098
http://dx.doi.org/10.1002/1878-0261.12456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487710/
https://www.ncbi.nlm.nih.gov/pubmed/30672098
http://dx.doi.org/10.1002/1878-0261.12456

Ejemplares similares